Precise and compliant core documentation is crucial for the successful execution and outcome translation of Investigator-Initiated Trials (IIT) in China. We offer end-to-end authoring services for all essential documents, from the Investigator’s Brochure (IB) to the Drug Manual. With a deep understanding of both Chinese and international regulatory systems, we ensure every document is scientifically robust and fully aligned with NMPA requirements. By delivering high-quality documentation, we help IIT projects proceed efficiently and accelerate the compliant translation and clinical application of research outcomes.
